A retrospective study conducted by a team of NCI researchers is dispelling the widely held notion that small cell lung cancer is almost exclusively tied to a history of smoking.
In 1995, a group of doctors who advocated treating breast cancer with high dose chemotherapy with bone marrow transplantation made an attempt to include that highly toxic procedure in the guidelines of the nascent National Comprehensive Cancer Network.
Late in 1997, when Bruce Ross told me that Bill McGivney would replace him as CEO of the National Comprehensive Cancer Network, I thought the recruitment made sense.
NCI recently announced a master plan for its $500 million Childhood Cancer Data Initiative, a pilot project designed to set the stage for building a publicly accessible, comprehensive data federation for all cancers (The Cancer Letter, Dec. 4, 2020).
The National Comprehensive Cancer Network, an organization that promulgates guidelines based on standards of care provided at academic institutions in the U.S., is indisputably one of the pillars of oncology today.
Last year, Fox Chase Cancer Center stood poised to make history by becoming the first NCI-designated cancer center to be sold on open market.
On Monday, March 1, Adekunle “Kunle” Odunsi will become the director of the University of Chicago Comprehensive Cancer Center—and the second Black director of an NCI-designated cancer center.
Five academic cancer centers have formed a unique research alliance, Break Through Cancer, to focus on four cancer types—pancreatic cancer, ovarian cancer, glioblastoma, and acute myelogenous leukemia.
As she became president of the American Society of Clinical Oncology, Lori J. Pierce decided to focus on equity in cancer care as her year-long presidential theme.
In a matter of months, cancer researchers have gone from grappling with a surge of COVID-19 with limited clinical data to playing a critical role in the development of successful mRNA vaccines against the disease.
